Our data validated that more than 97.6%, 95.8%, and 94.0% of recruited microglia in response to AD CM in the central chamber expressed the higher level of CD11b, CD86, and iNOS, respectively (Figure 2b). This evidence concerns the gene ITGAM and Alzheimer disease.